Copyright Reports & Markets. All rights reserved.

Global Therapeutic Apheresis Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Therapeutic Apheresis Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Trolley Type
    • 1.3.3 Desktop Type
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Therapeutic Apheresis Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
    • 1.4.5 Experimental Study
    • 1.4.6 Other
  • 1.5 Global Therapeutic Apheresis Devices Market Size & Forecast
    • 1.5.1 Global Therapeutic Apheresis Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Therapeutic Apheresis Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Therapeutic Apheresis Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Asahi Kasei Medical
    • 2.1.1 Asahi Kasei Medical Details
    • 2.1.2 Asahi Kasei Medical Major Business
    • 2.1.3 Asahi Kasei Medical Therapeutic Apheresis Devices Product and Services
    • 2.1.4 Asahi Kasei Medical Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Asahi Kasei Medical Recent Developments/Updates
  • 2.2 B.Braun
    • 2.2.1 B.Braun Details
    • 2.2.2 B.Braun Major Business
    • 2.2.3 B.Braun Therapeutic Apheresis Devices Product and Services
    • 2.2.4 B.Braun Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 B.Braun Recent Developments/Updates
  • 2.3 Fresenius Kabi
    • 2.3.1 Fresenius Kabi Details
    • 2.3.2 Fresenius Kabi Major Business
    • 2.3.3 Fresenius Kabi Therapeutic Apheresis Devices Product and Services
    • 2.3.4 Fresenius Kabi Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Fresenius Kabi Recent Developments/Updates
  • 2.4 Nigale
    • 2.4.1 Nigale Details
    • 2.4.2 Nigale Major Business
    • 2.4.3 Nigale Therapeutic Apheresis Devices Product and Services
    • 2.4.4 Nigale Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Nigale Recent Developments/Updates
  • 2.5 Miltenyi Biotec
    • 2.5.1 Miltenyi Biotec Details
    • 2.5.2 Miltenyi Biotec Major Business
    • 2.5.3 Miltenyi Biotec Therapeutic Apheresis Devices Product and Services
    • 2.5.4 Miltenyi Biotec Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Miltenyi Biotec Recent Developments/Updates
  • 2.6 Terumo
    • 2.6.1 Terumo Details
    • 2.6.2 Terumo Major Business
    • 2.6.3 Terumo Therapeutic Apheresis Devices Product and Services
    • 2.6.4 Terumo Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Terumo Recent Developments/Updates
  • 2.7 Lmb Technologie
    • 2.7.1 Lmb Technologie Details
    • 2.7.2 Lmb Technologie Major Business
    • 2.7.3 Lmb Technologie Therapeutic Apheresis Devices Product and Services
    • 2.7.4 Lmb Technologie Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Lmb Technologie Recent Developments/Updates
  • 2.8 JMS Singapore
    • 2.8.1 JMS Singapore Details
    • 2.8.2 JMS Singapore Major Business
    • 2.8.3 JMS Singapore Therapeutic Apheresis Devices Product and Services
    • 2.8.4 JMS Singapore Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 JMS Singapore Recent Developments/Updates
  • 2.9 Sichuan Lantaina Detai Biotechnology
    • 2.9.1 Sichuan Lantaina Detai Biotechnology Details
    • 2.9.2 Sichuan Lantaina Detai Biotechnology Major Business
    • 2.9.3 Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Product and Services
    • 2.9.4 Sichuan Lantaina Detai Biotechnology Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sichuan Lantaina Detai Biotechnology Recent Developments/Updates
  • 2.10 Haemonetics
    • 2.10.1 Haemonetics Details
    • 2.10.2 Haemonetics Major Business
    • 2.10.3 Haemonetics Therapeutic Apheresis Devices Product and Services
    • 2.10.4 Haemonetics Therapeutic Apheresis Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Haemonetics Recent Developments/Updates

3 Competitive Environment: Therapeutic Apheresis Devices by Manufacturer

  • 3.1 Global Therapeutic Apheresis Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Therapeutic Apheresis Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Therapeutic Apheresis Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Therapeutic Apheresis Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Therapeutic Apheresis Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Therapeutic Apheresis Devices Manufacturer Market Share in 2025
  • 3.5 Therapeutic Apheresis Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Therapeutic Apheresis Devices Market: Region Footprint
    • 3.5.2 Therapeutic Apheresis Devices Market: Company Product Type Footprint
    • 3.5.3 Therapeutic Apheresis Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Therapeutic Apheresis Devices Market Size by Region
    • 4.1.1 Global Therapeutic Apheresis Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Therapeutic Apheresis Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Therapeutic Apheresis Devices Average Price by Region (2021-2032)
  • 4.2 North America Therapeutic Apheresis Devices Consumption Value (2021-2032)
  • 4.3 Europe Therapeutic Apheresis Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Therapeutic Apheresis Devices Consumption Value (2021-2032)
  • 4.5 South America Therapeutic Apheresis Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Therapeutic Apheresis Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Therapeutic Apheresis Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Therapeutic Apheresis Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Therapeutic Apheresis Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Therapeutic Apheresis Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Therapeutic Apheresis Devices Market Size by Country
    • 7.3.1 North America Therapeutic Apheresis Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Therapeutic Apheresis Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Therapeutic Apheresis Devices Market Size by Country
    • 8.3.1 Europe Therapeutic Apheresis Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Therapeutic Apheresis Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Therapeutic Apheresis Devices Market Size by Region
    • 9.3.1 Asia-Pacific Therapeutic Apheresis Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Therapeutic Apheresis Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Therapeutic Apheresis Devices Market Size by Country
    • 10.3.1 South America Therapeutic Apheresis Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Therapeutic Apheresis Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Therapeutic Apheresis Devices Market Size by Country
    • 11.3.1 Middle East & Africa Therapeutic Apheresis Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Therapeutic Apheresis Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Therapeutic Apheresis Devices Market Drivers
  • 12.2 Therapeutic Apheresis Devices Market Restraints
  • 12.3 Therapeutic Apheresis Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Therapeutic Apheresis Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Therapeutic Apheresis Devices
  • 13.3 Therapeutic Apheresis Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Therapeutic Apheresis Devices Typical Distributors
  • 14.3 Therapeutic Apheresis Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Therapeutic Apheresis Devices market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Therapeutic Apheresis Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Therapeutic Apheresis Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Therapeutic Apheresis Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Therapeutic Apheresis Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Therapeutic Apheresis Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Therapeutic Apheresis Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Therapeutic Apheresis Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asahi Kasei Medical, B.Braun, Fresenius Kabi, Nigale, Miltenyi Biotec, Terumo, Lmb Technologie, JMS Singapore, Sichuan Lantaina Detai Biotechnology, Haemonetics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Therapeutic Apheresis Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Trolley Type
    Desktop Type
    Market segment by Application
    Hospital
    Clinic
    Other
    Experimental Study
    Other
    Major players covered
    Asahi Kasei Medical
    B.Braun
    Fresenius Kabi
    Nigale
    Miltenyi Biotec
    Terumo
    Lmb Technologie
    JMS Singapore
    Sichuan Lantaina Detai Biotechnology
    Haemonetics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Therapeutic Apheresis Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Therapeutic Apheresis Devices, with price, sales quantity, revenue, and global market share of Therapeutic Apheresis Devices from 2021 to 2026.
    Chapter 3, the Therapeutic Apheresis Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Therapeutic Apheresis Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Therapeutic Apheresis Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Apheresis Devices.
    Chapter 14 and 15, to describe Therapeutic Apheresis Devices sales channel, distributors, customers, research findings and conclusion.

    Buy now